Ten Pao Group Unveiled AI Humanoid Robot Smart Charger and New Energy Solutions at 2025 Hong Kong Electronics Fair (Autumn Edition), Driving an Intelligent and Green Future

HONG KONG, Oct. 15, 2025 /PRNewswire/ -- Ten Pao Group Holdings Limited ("Ten Pao" or the "Group", Stock Code: 1979.HK), a leading provider of new energy and AI power solutions in China, participated in the 2025 Hong Kong Electronics Fair (Autumn Edition) organised by the Hong Kong Trade Development Council from 13 to 16 October. Under the theme of "AI Empowering Ten Pao Power Solution", the Group welcomed investors, business partners and industry professionals to its booth for first-hand insights into Ten Pao's latest breakthroughs in AI technology and new energy area, as well as the future development strategy.

At the exhibition, Ten Pao presented a comprehensive showcase of its innovations in power production and product development under the wave of AI technology. The exhibition area highlighted four major focus areas – Digital Factory, Intelligent Factory, Green Factory and New Quality Productivity, presenting AI power products and AI power solutions. Through AI power manufacturing, the Group has enhanced production efficiency and energy utilisation, supporting a low-carbon and sustainable industrial transformation.

Regarding the AI power products and solutions, Ten Pao featured its advanced innovations including the AI server computing power supply, AI humanoid robot smart battery charger, and high-end smart controllers (PCBA), demonstrating the Group's strong R&D capability and market foresight in the AI power sector. The newly launched 3,500W high-power supply product is designed for high-performance computing environments such as cloud data centres, HPC systems and enterprise-grade servers, offering improved stability and operational efficiency for AI computing equipment.

As for the new energy segment, Ten Pao continues to capture opportunities arising from the global "fuel-to-electric" transition and carbon neutrality. The Group showcased its diversified product portfolio, including home and portable energy systems, electric vehicle battery-swap cabinet and fast-charging station, serving a variety of application scenarios such as household, industrial and urban transportation. Its self-developed energy storage modules have increased to 6,000W in output, catering to varying regional energy structures and consumption demands. The Group is also actively participating in Southeast Asia's new energy infrastructure projects, such as Thailand's two-wheeler electric vehicle battery-swap cabinet and fast-charging station projects, further strengthening
Ten Pao's strategic presence in the green energy market.

During the exhibition, Ten Pao's diversified product portfolio and technological innovations attracted significant interest from international clients. The management team engaged with global partners to explore future collaboration opportunities. While certain products remain in the research and development or pilot production phase, the products have strong market potential, particularly in the AI power and energy storage fields, which are expected to serve as major growth engines for the Group in the next phase.

Looking ahead, Ten Pao will continue to accelerate the integration of AI and new energy technologies, upgrade its product mix, and advance its transition towards high-end intelligent manufacturing. With the expansion of its Huizhou Intelligent Manufacturing Industrial Park, the Group's overall production capacity and automation level have been significantly enhanced. Backed by its innovation-driven strategy, intelligent manufacturing capabilities and global production layout, Ten Pao is confident in capturing new opportunities, expanding its business scale, and steering towards a new stage of high-quality and sustainable development.

About Ten Pao Group

Established in 1979, Ten Pao has 46 years of experience in power supply industry. It has been listed on the Main Board of the Hong Kong Stock Exchange since 2015. With the development direction of high-end and digital intelligence, it continues to provide customers with "intelligent, efficient, safe, reliable, and rapid response" product customization and production manufacturing services, whilst offering "one-stop" intelligent power supply solutions with market competitiveness. Over the years, Ten Pao has established a long-term stable cooperative relationship with many well-known international brands and become an international leading, reliable and innovative power supply group.

This press release was distributed by DLK Advisory on behalf of Ten Pao Group Holdings Limited.

DLK Advisory

Tel: +852 2857 7101
Fax: +852 2857 7103

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Ten Pao Group Unveiled AI Humanoid Robot Smart Charger and New Energy Solutions at 2025 Hong Kong Electronics Fair (Autumn Edition), Driving an Intelligent and Green Future

HANGZHOU, China, April 3, 2026 /PRNewswire/ -- A team led by principal investigators Bobo Dang and Ting Zhou at Westlake University/Westlake Laboratory reported in Science a high-throughput platform for engineering fast-acting covalent protein therapeutics. Their work, titled "A high-throughput selection system for fast-acting covalent protein drugs," opens new avenues for next-generation biologics.

Covalent small-molecule drugs have shown great success in cancer therapy by forming irreversible bonds with their targets. This has inspired efforts to extend covalent strategies to protein therapeutics, especially engineered miniproteins. However, their development is limited by a kinetic mismatch: Miniproteins are rapidly cleared in vivo, whereas covalent bond formation is typically slow. In addition, high-throughput platforms for systematically optimizing covalent protein reactivity have been lacking.

To address this challenge, the researchers proposed that precise spatial positioning of chemical warheads within protein scaffolds could enable molecular preorganization, thereby accelerating covalent bond formation without increasing intrinsic reactivity (Fig. 1).

Based on this concept, the team developed a high-throughput platform that combines yeast surface display with chemoselective protein modification to screen diverse crosslinkers and millions of protein variants. By optimizing warhead placement and the local chemical environment, the platform enables rapid and irreversible target engagement.

Using this platform, the researchers developed a covalent antagonist targeting PD-L1, termed IB101. Structural analysis revealed that IB101 forms a defined binding pocket that precisely positions the warhead in a reactive conformation, greatly accelerating covalent bond formation. Functionally, IB101 effectively blocks the PD-1/PD-L1 immune checkpoint pathway and demonstrates strong antitumor activity in mouse models. Notably, despite its short in vivo half-life, IB101 achieves durable target engagement and tumor suppression, outperforming conventional antibody-based therapies under comparable conditions.

The platform was further applied to cytokine engineering, leading to the development of a covalent IL-18 variant, IB201. This engineered cytokine rapidly forms a covalent interaction with its receptor, enhancing signaling strength and duration. In vivo studies showed that IB201 induces potent antitumor immune responses without detectable systemic toxicity. These results highlight the potential of covalent engineering to improve the efficacy and safety of cytokine-based therapies.

Beyond immunotherapy targets, the platform was also applied to develop a covalent inhibitor targeting the receptor-binding domain (RBD) of SARS-CoV-2. This molecule achieves durable viral neutralization, demonstrating the versatility of the approach across different therapeutic modalities.

This study establishes a general strategy for engineering fast-acting covalent protein therapeutics. By enabling covalent bond formation on timescales compatible with rapid in vivo clearance, the platform overcomes a fundamental limitation in the field.

These findings provide a new framework for designing biologics with both rapid kinetics and sustained target engagement, with broad implications for cancer immunotherapy, antiviral therapy, and beyond.

Media Contact: 

Chi Zhang
media@westlake.edu.cn 
+86-15659837873

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Fast-Acting Covalent Protein Drugs From a New High-Throughput Platform